Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at V940 and pembrolizumab to improve treatment for squamous cell skin cancer (INTerpath-007)

Overview

Cancer types:

Skin cancer

Status:

Closed

Phase:

Phase 2/3

Details

This trial is looking at 2 drugs called V940 and pembrolizumab for locally advanced squamous cell skin cancer.

The trial is for people who:

  • have cancer that has spread into the surrounding tissues and it is possible to treat it with surgery

  • have not had cancer treatment

Recruitment start: 30 August 2024

Recruitment end: 16 December 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Will Ince

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 19 Dec 2024

CRUK internal database number: 19948

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.